Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin

BackgroundThe prevalence of diabetes is predicted to rise significantly in the coming decades. A recent analysis projects that by the year 2030 there will be ~366 million diabetics around the world, leading to an increased demand for inexpensive insulin to make this life-saving drug also affordable for resource poor countries.ResultsA synthetic insulin precursor (IP)-encoding gene, codon-optimized for expression in P. pastoris, was cloned in frame with the Saccharomyces cerevisiae α-factor secretory signal and integrated into the genome of P. pastoris strain X-33. The strain was grown to high-cell density in a batch procedure using a defined medium with low salt and high glycerol concentrations. Following batch growth, production of IP was carried out at methanol concentrations of 2 g L-1, which were kept constant throughout the remaining production phase. This robust feeding strategy led to the secretion of ~3 gram IP per liter of culture broth (corresponding to almost 4 gram IP per liter of cell-free culture supernatant). Using immobilized metal ion affinity chromatography (IMAC) as a novel approach for IP purification, 95% of the secreted product was recovered with a purity of 96% from the clarified culture supernatant. Finally, the purified IP was trypsin digested, transpeptidated, deprotected and further purified leading to ~1.5 g of 99% pure recombinant human insulin per liter of culture broth.ConclusionsA simple two-phase cultivation process composed of a glycerol batch and a constant methanol fed-batch phase recently developed for the intracellular production of the Hepatitis B surface antigen was adapted to secretory IP production. Compared to the highest previously reported value, this approach resulted in an ~2 fold enhancement of IP production using Pichia based expression systems, thus significantly increasing the efficiency of insulin manufacture.

[1]  J. Cregg,et al.  Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. , 2002, Current opinion in biotechnology.

[2]  A. Riggs,et al.  Expression in Escherichia coli of chemically synthesized genes for human insulin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Corrigendum to: ‘A removable spacer peptide in an α-factor-leader/insulin precursor fusion protein improves processing and concomitant yield of the insulin precursor in Saccharomyces cerevisiae’ [Gene 170(1996)107–112] , 1996 .

[4]  K. Morihara,et al.  Influence of temperature on the enzymic semisynthesis of human insulin by coupling and transpeptidation methods. , 1986, The Biochemical journal.

[5]  C. Hollenberg,et al.  Application of yeasts in gene expression studies: a comparison of Saccharomyces cerevisiae, Hansenula polymorpha and Kluyveromyces lactis -- a review. , 1997, Gene.

[6]  Navin Khanna,et al.  Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen , 2009, Microbial cell factories.

[7]  W. Duckworth,et al.  Recombinant DNA technology in the treatment of diabetes: insulin analogs. , 2001, Endocrine reviews.

[8]  Michael Sauer,et al.  Recombinant protein production in yeasts. , 2012, Methods in molecular biology.

[9]  J. Valdés,et al.  Modeling of mini-proinsulin production in Pichia pastoris using the AOX promoter , 2003, Biotechnology Letters.

[10]  H. Liu,et al.  Secretory Expression of Insulin Precursor in Pichia pastoris and Simple Procedure for Producing Recombinant Human Insulin , 2008, Preparative biochemistry & biotechnology.

[11]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[12]  Pingzuo Li,et al.  Expression of Recombinant Proteins in Pichia Pastoris , 2007, Applied biochemistry and biotechnology.

[13]  M. Egel-Mitani,et al.  A removable spacer peptide in an α-factor-leader/insulin precursor fusion protein improves processing and concomitant yield of the insulin precursor in Saccharomyces cerevisiae , 1996 .

[14]  T. Kjeldsen,et al.  Secretory expression and characterization of insulin in Pichia pastoris , 1999, Biotechnology and applied biochemistry.

[15]  M. Uhlén,et al.  Integrated production of human insulin and its C-peptide. , 1996, Journal of biotechnology.

[16]  M. Kula,et al.  Expanded bed adsorption as a primary recovery step for the isolation of the insulin precursor MI3 process development and scale up , 2006, Biotechnology and bioengineering.

[17]  B. Ahmad Review: Pharmacology of insulin: , 2004 .

[18]  C. Hollenberg,et al.  Production of recombinant proteins by methylotrophic yeasts. , 1997, Current opinion in biotechnology.

[19]  T. Kjeldsen,et al.  Yeast secretory expression of insulin precursors , 2000, Applied Microbiology and Biotechnology.

[20]  L. Thim,et al.  Secretion and processing of insulin precursors in yeast. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Piontek,et al.  High-level secretion of hirudin by Hansenula polymorpha —authentic processing of three different preprohirudins , 1995, Applied Microbiology and Biotechnology.

[22]  Y. Zhuang,et al.  Efficient generation of multi‐copy strains for optimizing secretory expression of porcine insulin precursor in yeast Pichia pastoris , 2009, Journal of applied microbiology.

[23]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[24]  V. Besada,et al.  Improving the expression of mini-proinsulin in Pichia pastoris , 2004, Biotechnology Letters.

[25]  U. Rinas,et al.  Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli. , 1999, Journal of biotechnology.

[26]  D. Cui,et al.  Expression of monomeric insulin precursor in Pichia pastoris and its conversion into monomeric B27 Lys destripeptide insulin by tryptic hydrolysis. , 2005, Acta biochimica et biophysica Sinica.

[27]  V. Ramesh,et al.  1H NMR studies of insulin: histidine residues, metal binding, and dissociation in alkaline solution. , 1987, Archives of biochemistry and biophysics.

[28]  Gary Walsh,et al.  Therapeutic insulins and their large-scale manufacture , 2005, Applied Microbiology and Biotechnology.

[29]  L. Harvey,et al.  Heterologous protein production using the Pichia pastoris expression system , 2005, Yeast.

[30]  Y Wang,et al.  Human insulin from a precursor overexpressed in the methylotrophic yeast Pichia pastoris and a simple procedure for purifying the expression product. , 2001, Biotechnology and bioengineering.

[31]  Antonio Villaverde,et al.  Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview , 2008 .

[32]  Michael Sauer,et al.  Recombinant protein production in yeasts , 2005, Molecular biotechnology.

[33]  S. Swaminathan,et al.  Expression of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris using the GAP promoter. , 2001, Journal of biotechnology.

[34]  L. Thim,et al.  BIOSYNTHESIS OF HUMAN INSULIN IN YEAST VIA SINGLE-CHAIN PRECURSORS , 1987 .

[35]  M. Romanos Advances in the use of Pichia pastoris for high-level gene expression , 1995 .

[36]  M. Dunn,et al.  Comparison of solution structural flexibility and zinc binding domains for insulin, proinsulin, and miniproinsulin. , 1989, Biochemistry.

[37]  M. Morange,et al.  Microbial Cell Factories , 2006 .

[38]  Esther Vázquez,et al.  Microbial factories for recombinant pharmaceuticals , 2009 .

[39]  V. Besada,et al.  Multiple gene copy number enhances insulin precursor secretion in the yeast Pichia pastoris , 2005, Biotechnology Letters.

[40]  A. Burden The pharmacology of insulin , 1988 .

[41]  T. L. Coombs,et al.  Differences in the nature of the interaction of insulin and proinsulin with zinc. , 1972, The Biochemical journal.